AstraZeneca PLC (AZN) Price Prediction & ForecastAZNForecastAstraZeneca PLC

Alphio's AZN stock price prediction model matches the current AstraZeneca PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $162.21 (-0.30%). The 1-week path is $167.53 (+2.97%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

AstraZeneca PLC (AZN) is a good buy right now, trading at $162.70 with a forward P/E of 16.23, indicating attractive valuation compared to its growth potential. The stock has shown a remarkable year-to-date change of +77.68% and a one-year change of +102.89%, reflecting strong performance. The recent acquisition of Zegfrovy for $600 million, with potential total commitments of $1.5 billion, demonstrates AstraZeneca's strategic growth plans in oncology, which could drive future revenue. However, the RSI is currently at 42.88, suggesting the stock is nearing oversold territory, which may present a buying opportunity. The main risk is the discontinuation of the lung cancer trial, which could affect investor sentiment and future earnings potential.

AstraZeneca PLC (AZN) last closed at $162.7, losing -1.11%. These facts feed the 1-day and 1-week AZN price prediction above.